Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Rebuzzi SE, Brunelli M, Galuppini F, Vellone VG, Signori A, Catalano F, Damassi A, Gaggero G, Rescigno P, Maruzzo M, Merler S, Vignani F, Cavo A, Basso U, Milella M, Panepinto O, Mencoboni M, Sbaraglia M, Dei Tos AP, Murianni V, Cremante M, Llaja Obispo MA, Maffezzoli M, Banna GL, Buti S, Fornarini G. Rebuzzi SE, et al. Among authors: dei tos ap. Cancers (Basel). 2023 Apr 21;15(8):2394. doi: 10.3390/cancers15082394. Cancers (Basel). 2023. PMID: 37190322 Free PMC article.
Digital pathology world tour.
Rizzo PC, Caputo A, Maddalena E, Caldonazzi N, Girolami I, Dei Tos AP, Scarpa A, Sbaraglia M, Brunelli M, Gobbo S, Marletta S, Pantanowitz L, Della Mea V, Eccher A. Rizzo PC, et al. Among authors: dei tos ap. Digit Health. 2023 Aug 29;9:20552076231194551. doi: 10.1177/20552076231194551. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 37654717 Free PMC article. Review.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Catalano F, Brunelli M, Signori A, Rescigno P, Buti S, Galli L, Spada M, Masini C, Galuppini F, Vellone VG, Gaggero G, Maruzzo M, Merler S, Vignani F, Cavo A, Bimbatti D, Milella M, Dei Tos AP, Sbaraglia M, Murianni V, Damassi A, Cremante M, Maffezzoli M, Llaja Obispo MA, Banna GL, Fornarini G, Rebuzzi SE. Catalano F, et al. Among authors: dei tos ap. Future Oncol. 2024 Apr 29. doi: 10.2217/fon-2023-1068. Online ahead of print. Future Oncol. 2024. PMID: 38682738
Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions.
Cazzaniga G, Rossi M, Eccher A, Girolami I, L'Imperio V, Van Nguyen H, Becker JU, Bueno García MG, Sbaraglia M, Dei Tos AP, Gambaro G, Pagni F. Cazzaniga G, et al. Among authors: dei tos ap. J Nephrol. 2024 Jan;37(1):65-76. doi: 10.1007/s40620-023-01775-w. Epub 2023 Sep 28. J Nephrol. 2024. PMID: 37768550 Free PMC article. Review.
Natural Language Processing to extract SNOMED-CT codes from pathological reports.
Cazzaniga G, Eccher A, Munari E, Marletta S, Bonoldi E, Della Mea V, Cadei M, Sbaraglia M, Guerriero A, Dei Tos AP, Pagni F, L'Imperio V. Cazzaniga G, et al. Among authors: dei tos ap. Pathologica. 2023 Dec;115(6):318-324. doi: 10.32074/1591-951X-952. Pathologica. 2023. PMID: 38180139 Free PMC article.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
Miglietta F, Carraro V, Amato O, Griguolo G, Bottosso M, Munari G, Zarrilli G, Lo Mele M, Barbieri C, Dei Tos AP, Guarneri V, Dieci MV, Fassan M. Miglietta F, et al. Among authors: dei tos ap. J Clin Pathol. 2023 Jun 21:jcp-2023-208856. doi: 10.1136/jcp-2023-208856. Online ahead of print. J Clin Pathol. 2023. PMID: 37344170 Free article.
489 results